Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at the Jefferies 2017 Global Healthcare Conference

CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
May 10, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Presents Data on Ophthalmic Solithromycin at ARVO

CHAPEL HILL, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 28, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., April 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 21, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Presents Data at ECCMID Highlighting Need for New CABP Therapies and Activity of Solithromycin in Key Population Groups

CHAPEL HILL, N.C., April 21, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 13, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Report First Quarter 2017 Financial Results

CHAPEL HILL, N.C., April 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
March 29, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at the 16th Annual Needham & Company Healthcare Conference

CHAPEL HILL, N.C., March 29, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
March 28, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

CHAPEL HILL, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
March 13, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options

CHAPEL HILL, N.C., March 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
March 03, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at 29th Annual ROTH Conference

CHAPEL HILL, N.C., March 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
February 28, 2017 06:45 ET | Source: Cempra, Inc.

Cempra Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

—Management to host webcast and conference call today at 8:45 a.m. ET— CHAPEL HILL, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right